Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).


CSE:IMCC - Post by User

Post by RockMaschineon Aug 15, 2022 8:32am
169 Views
Post# 34896046

Almost $100 million annual at 50% off

Almost $100 million annual at 50% off
Trading a about 0.5 price to sales. $5 million cash is low but actually better than I expected. Based on cost saving measures and margin growth should mean no need to raise cash. I don't think they want to given the price of previous raises being closer to $5US. I've noticed the new products in the stores. Israel has yet to see significant growth due to patients being delayed getting their medical cards. Still no progress on the rec front, or at least nothing in local news that I can find. Once Germany figures out how to get their country through winter than maybe they'll focus on small time stuff like cannabis. Expected growing pains but I have patience. Will need to listen to the call later.
<< Previous
Bullboard Posts
Next >>